BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Holcar M, Kandušer M, Lenassi M. Blood Nanoparticles - Influence on Extracellular Vesicle Isolation and Characterization. Front Pharmacol 2021;12:773844. [PMID: 34867406 DOI: 10.3389/fphar.2021.773844] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Biagiotti S, Abbas F, Montanari M, Barattini C, Rossi L, Magnani M, Papa S, Canonico B. Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs. Pharmaceutics 2023;15. [PMID: 36839687 DOI: 10.3390/pharmaceutics15020365] [Reference Citation Analysis]
2 Williams S, Jalal AR, Lewis MP, Davies OG. A survey to evaluate parameters governing the selection and application of extracellular vesicle isolation methods. J Tissue Eng 2023;14:20417314231155114. [PMID: 36911574 DOI: 10.1177/20417314231155114] [Reference Citation Analysis]
3 Zhen K, Wei X, Zhi Z, Zhang S, Cui L, Li Y, Chen X, Yao J, Zhang H. Comparison of Different Isolation Methods for Plasma-Derived Extracellular Vesicles in Patients with Hyperlipidemia. Life (Basel) 2022;12. [PMID: 36431076 DOI: 10.3390/life12111942] [Reference Citation Analysis]
4 Ridolfi A, Conti L, Brucale M, Frigerio R, Cardellini J, Musicò A, Romano M, Zendrini A, Polito L, Bergamaschi G, Gori A, Montis C, Barile L, Berti D, Radeghieri A, Bergese P, Cretich M, Valle F. Compositional profiling of EV-lipoprotein mixtures by AFM nanomechanical imaging.. [DOI: 10.1101/2022.07.19.500441] [Reference Citation Analysis]
5 Chang T, Wu C, Chiou S, Chang C, Liao H. Adipose-Derived Stem Cell Exosomes as a Novel Anti-Inflammatory Agent and the Current Therapeutic Targets for Rheumatoid Arthritis. Biomedicines 2022;10:1725. [DOI: 10.3390/biomedicines10071725] [Reference Citation Analysis]
6 Liew OW, Fanusi F, Ng JYX, Ahidjo BA, Ling SSM, Lilyanna S, Chong JPC, Lim AES, Lim WZ, Ravindran S, Chu JJH, Lim SL, Richards AM. Immunoassay-Compatible Inactivation of SARS-CoV-2 in Plasma Samples for Enhanced Handling Safety. ACS Omega. [DOI: 10.1021/acsomega.2c02585] [Reference Citation Analysis]
7 Panachan J, Rojsirikulchai N, Pongsakul N, Khowawisetsut L, Pongphitcha P, Siriboonpiputtana T, Chareonsirisuthigul T, Phornsarayuth P, Klinkulab N, Jinawath N, Chiangjong W, Anurathapan U, Pattanapanyasat K, Hongeng S, Chutipongtanate S. Extracellular Vesicle-Based Method for Detecting MYCN Amplification Status of Pediatric Neuroblastoma. Cancers (Basel) 2022;14:2627. [PMID: 35681607 DOI: 10.3390/cancers14112627] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ghosh S, Ghosh S. Exosome: The “Off-the-Shelf” Cellular Nanocomponent as a Potential Pathogenic Agent, a Disease Biomarker, and Neurotherapeutics. Front Pharmacol 2022;13:878058. [DOI: 10.3389/fphar.2022.878058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Soukup J, Kostelanská M, Kereïche S, Hujacová A, Pavelcová M, Petrák J, Kubala Havrdová E, Holada K. Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease. J Clin Med 2022;11:2832. [PMID: 35628959 DOI: 10.3390/jcm11102832] [Reference Citation Analysis]
10 Khan A, Di K, Khan H, He N, Li Z. Rapid Capturing and Chemiluminescent Sensing of Programmed Death Ligand-1 Expressing Extracellular Vesicles. Biosensors 2022;12:281. [DOI: 10.3390/bios12050281] [Reference Citation Analysis]